Cargando...
Comparing the Immune-Genomic Effects of Vilazodone and Paroxetine in Late-Life Depression: A Pilot Study
BACKGROUND: Vilazodone is a novel antidepressant agent that combines selective serotonin (5-HT) reuptake inhibitor (SSRI) activity and 5-HT(1A) receptor partial agonist activity. OBJECTIVE: A pilot study was conducted to compare vilazodone (novel compound) and paroxetine (gold standard) on antidepre...
Guardado en:
| Publicado en: | Pharmacopsychiatry |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5656542/ https://ncbi.nlm.nih.gov/pubmed/28444658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0043-107033 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|